UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023074
Receipt number R000025422
Scientific Title LARGE BOWEL OBSTRUCTION OR PERFORATION CAUSED BY ORAL PREPARATION FOR COLONOSCOPY (Retrospective study)
Date of disclosure of the study information 2016/07/08
Last modified on 2016/07/08 11:31:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

LARGE BOWEL OBSTRUCTION OR PERFORATION CAUSED BY ORAL PREPARATION FOR COLONOSCOPY (Retrospective study)

Acronym

LARGE BOWEL OBSTRUCTION OR PERFORATION CAUSED BY ORAL PREPARATION FOR COLONOSCOPY

Scientific Title

LARGE BOWEL OBSTRUCTION OR PERFORATION CAUSED BY ORAL PREPARATION FOR COLONOSCOPY (Retrospective study)

Scientific Title:Acronym

LARGE BOWEL OBSTRUCTION OR PERFORATION CAUSED BY ORAL PREPARATION FOR COLONOSCOPY

Region

Japan


Condition

Condition

LARGE BOWEL OBSTRUCTION OR PERFORATION

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Patients undergoing bowel preparation for colonoscopy are at risk of potentially severe adverse events such as large-bowel obstruction (LBO) and perforation. These patients usually need emergency surgery and the events are sometimes fatal; however, details of these adverse events are unknown. The present study is an initial systematic report that analyzes LBO and perforation caused by oral preparation for colonoscopy.

Basic objectives2

Others

Basic objectives -Others

adverse events

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We evaluated 10 clinical factors for each patient: age, sex, symptoms at the first visit, preparation drug, location of LBO/perforation, pathogenesis, rate of surgery, rate of emergency surgery, rate of colostomy and mortality. From these data, we analyzed the pathogenesis of LBO and perforation, and we propose prophylactic measures for these adverse events.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The subjects of the study were patients at Showa University Northern Yokohama Hospital between April 2001 and December 2015, who were diagnosed with LBO or perforation caused by oral preparations.

Key exclusion criteria

none

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akihiro Yamauchi

Organization

Showa University Northern Yokohama Hospital

Division name

Digestive Disease Center

Zip code


Address

35-1, Chigasaki-Chuo Tsuzuki-ku, Yokohama-shi, Kanagawa 224-8503 Japan

TEL

09024540053

Email

showyou0913@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Akihiro Yamauchi

Organization

Showa University Northern Yokohama Hospital

Division name

Digestive Disease Center

Zip code


Address

35-1, Chigasaki-Chuo Tsuzuki-ku, Yokohama-shi, Kanagawa 224-8503 Japan

TEL

045-949-7000

Homepage URL


Email

showyou0913@gmail.com


Sponsor or person

Institute

Showa University Northern Yokohama Hospital, Digestive Disease Center

Institute

Department

Personal name



Funding Source

Organization

non

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

retrospective study


Management information

Registered date

2016 Year 07 Month 08 Day

Last modified on

2016 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025422


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name